Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY)
$ 15.07 -0.3 (-1.95%) Market Cap: 49.59 Bil Enterprise Value: 44.71 Bil PE Ratio: 23.98 PB Ratio: 4.77 GF Score: 93/100

Q2 2021 Chugai Pharmaceutical Co Ltd Earnings Call Transcript

Jul 26, 2021 / 08:00AM GMT
Release Date Price: $18.92 (+0.16%)
Osamu Okuda
Chugai Pharmaceutical Co., Ltd. - President, CEO & Representative Director

I am Dr. Osamu Okuda, President and CEO of Chugai Pharmaceutical. Let me give you the financial overview of the second quarter of fiscal 2021.

Please take a look at Page 5. Revenues from January through June totaled JPY 390.2 billion, up 6.0% year-on-year. The operating profit and net income for the second quarter soared by more than 15% from the year before. We started the first quarter with a drop in both revenues and profit but turning to positive year-on-year growth in revenues and profits for the first half.

Looking at the progress against the full year forecast. Domestic sales and ROI exceeded the forecast made at the beginning of the year. In particular, the growth in ROI was associated with the growth in overseas local sales of in-house products and, therefore, directly contributed to the profits. As a result, both operating profit and net income showed steady growth that surpassed the initial forecast.

As I explained in the next slide, in addition to those factors, there are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot